Innovation

Innovation: Cancer Vaccine by Stanford's Irving Weissman


Innovator: Irving Weissman 
Age: 73 
Title: Stanford Medical School director of stem cell biology and regenerative medicine 

Form and function: Creating antibodies capable of blocking the protein most cancer cells use to hide themselves from a body’s immune system.

Olga_kharif1
Kharif is a reporter for Bloomberg News and Bloomberg Businessweek in Portland, Ore.

Ebola Rising
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus